Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 153

1.

Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.

Tiwari AK, Brandl EJ, Weber C, Likhodi O, Zai CC, Hahn MK, Lieberman JA, Meltzer HY, Kennedy JL, Müller DJ.

J Clin Psychopharmacol. 2013 Feb;33(1):11-7. doi: 10.1097/JCP.0b013e31827d145a.

PMID:
23277265
[PubMed - indexed for MEDLINE]
2.

A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia.

Tiwari AK, Zai CC, Likhodi O, Lisker A, Singh D, Souza RP, Batra P, Zaidi SH, Chen S, Liu F, Puls I, Meltzer HY, Lieberman JA, Kennedy JL, Müller DJ.

Neuropsychopharmacology. 2010 May;35(6):1315-24. doi: 10.1038/npp.2009.235. Epub 2010 Jan 27.

PMID:
20107430
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients.

Tiwari AK, Zai CC, Meltzer HY, Lieberman JA, Müller DJ, Kennedy JL.

Hum Psychopharmacol. 2010 Apr;25(3):253-9. doi: 10.1002/hup.1111.

PMID:
20373477
[PubMed - indexed for MEDLINE]
4.

TNF-α -308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment.

Huang HH, Wang YC, Wu CL, Hong CJ, Bai YM, Tsai SJ, Liou YJ.

Neurosci Lett. 2011 Oct 31;504(3):277-80. doi: 10.1016/j.neulet.2011.09.046. Epub 2011 Sep 28.

PMID:
21967963
[PubMed - indexed for MEDLINE]
5.

Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain.

Souza RP, Tiwari AK, Chowdhury NI, Ceddia RB, Lieberman JA, Meltzer HY, Kennedy JL, Müller DJ.

J Psychiatr Res. 2012 Apr;46(4):462-8. doi: 10.1016/j.jpsychires.2012.01.010. Epub 2012 Feb 2.

PMID:
22305490
[PubMed - indexed for MEDLINE]
6.

Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients.

Tiwari AK, Rodgers JB, Sicard M, Zai CC, Likhodi O, Freeman N, Meltzer HY, Lieberman JA, Kennedy JL, Müller DJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Dec 1;34(8):1484-90. doi: 10.1016/j.pnpbp.2010.08.009. Epub 2010 Aug 20.

PMID:
20732371
[PubMed - indexed for MEDLINE]
7.

Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain.

Park YM, Choi JE, Kang SG, Koo SH, Kim L, Geum D, Lee HJ.

Hum Psychopharmacol. 2011 Jun-Jul;26(4-5):332-7. doi: 10.1002/hup.1210. Epub 2011 Jun 22.

PMID:
21695734
[PubMed - indexed for MEDLINE]
8.

Association of the common MC4R rs17782313 polymorphism with antipsychotic-related weight gain.

Czerwensky F, Leucht S, Steimer W.

J Clin Psychopharmacol. 2013 Feb;33(1):74-9. doi: 10.1097/JCP.0b013e31827772db.

PMID:
23277235
[PubMed - indexed for MEDLINE]
9.

Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment.

Hong CJ, Liou YJ, Bai YM, Chen TT, Wang YC, Tsai SJ.

Pharmacogenet Genomics. 2010 Jun;20(6):359-66. doi: 10.1097/FPC.0b013e3283397d06.

PMID:
20375926
[PubMed - indexed for MEDLINE]
10.

Association of the alpha 2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European-Americans.

Sickert L, Müller DJ, Tiwari AK, Shaikh S, Zai C, De Souza R, De Luca V, Meltzer HY, Lieberman JA, Kennedy JL.

Pharmacogenomics. 2009 Jul;10(7):1169-76. doi: 10.2217/pgs.09.43.

PMID:
19604092
[PubMed - indexed for MEDLINE]
11.

Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia.

Tiwari AK, Zai CC, Likhodi O, Voineskos AN, Meltzer HY, Lieberman JA, Potkin SG, Remington G, Müller DJ, Kennedy JL.

Pharmacogenomics J. 2012 Jun;12(3):260-6. doi: 10.1038/tpj.2010.93. Epub 2011 Jan 25.

PMID:
21266946
[PubMed - indexed for MEDLINE]
12.

Association study of brain-derived neurotrophic factor gene polymorphisms and body weight change in schizophrenic patients under long-term atypical antipsychotic treatment.

Tsai A, Liou YJ, Hong CJ, Wu CL, Tsai SJ, Bai YM.

Neuromolecular Med. 2011 Dec;13(4):328-33. doi: 10.1007/s12017-011-8159-5. Epub 2011 Sep 29.

PMID:
21956459
[PubMed - indexed for MEDLINE]
13.

Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?

Le Hellard S, Theisen FM, Haberhausen M, Raeder MB, Fernø J, Gebhardt S, Hinney A, Remschmidt H, Krieg JC, Mehler-Wex C, Nöthen MM, Hebebrand J, Steen VM.

Mol Psychiatry. 2009 Mar;14(3):308-17. doi: 10.1038/sj.mp.4002133. Epub 2008 Jan 15.

PMID:
18195716
[PubMed - indexed for MEDLINE]
14.

Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism.

Miller DD, Ellingrod VL, Holman TL, Buckley PF, Arndt S.

Am J Med Genet B Neuropsychiatr Genet. 2005 Feb 5;133B(1):97-100.

PMID:
15635667
[PubMed - indexed for MEDLINE]
15.

Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain.

Monteleone P, Milano W, Petrella C, Canestrelli B, Maj M.

J Clin Psychopharmacol. 2010 Aug;30(4):441-5. doi: 10.1097/JCP.0b013e3181e742c5.

PMID:
20631561
[PubMed - indexed for MEDLINE]
16.

Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.

Houston JP, Kohler J, Bishop JR, Ellingrod VL, Ostbye KM, Zhao F, Conley RR, Poole Hoffmann V, Fijal BA.

J Clin Psychiatry. 2012 Aug;73(8):1077-86. doi: 10.4088/JCP.11m06916.

PMID:
22967772
[PubMed - indexed for MEDLINE]
17.

Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3'-untranslated region.

Greenbaum L, Smith RC, Rigbi A, Strous R, Teltsh O, Kanyas K, Korner M, Lancet D, Ben-Asher E, Lerer B.

Pharmacogenomics J. 2009 Apr;9(2):103-10. doi: 10.1038/tpj.2008.6. Epub 2008 Mar 18.

PMID:
18347610
[PubMed - indexed for MEDLINE]
18.

Possible association between the -2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain.

Kang SG, Lee HJ, Park YM, Choi JE, Han C, Kim YK, Kim SH, Lee MS, Joe SH, Jung IK, Kim L.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):160-3. Epub 2007 Aug 14.

PMID:
17804136
[PubMed - indexed for MEDLINE]
19.

Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population.

Zhang XY, Tan YL, Zhou DF, Haile CN, Cao LY, Xu Q, Shen Y, Kosten TA, Kosten TR.

J Clin Psychopharmacol. 2007 Jun;27(3):246-51.

PMID:
17502770
[PubMed - indexed for MEDLINE]
20.

Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals.

Theisen FM, Hinney A, Brömel T, Heinzel-Gutenbrunner M, Martin M, Krieg JC, Remschmidt H, Hebebrand J.

Psychiatr Genet. 2004 Sep;14(3):139-42.

PMID:
15318026
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk